Original Research

JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Suicidal Ideation in Residential Substance Use Treatment
Original Research

May 22, 2023

People with substance use disorders (SUDs) and chronic health/psychiatric conditions may have higher risk for suicidal ideation than those with only SUD. Integrated treatments for patients with suicidal ideation...
, , , et al
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al
PCC
Screening and Referral Algorithm for Substance Use
Original Research

May 18, 2023

The New Hampshire Hospital Screening and Referral Algorithm, a new data driven substance use screening instrument, holds promise in improving identification of substance use in a seriously mentally ill...
, , , et al
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
Original Research

May 17, 2023

Among 430 youth beginning treatment for depression, about one-quarter achieved remission within 6 months. The odds of remitting decreased as baseline symptom severity increased.
, , , et al
PCC
Insomnia and Time Monitoring Behavior
Original Research

May 16, 2023

Time monitoring behavior and the associated frustration it engenders may perpetuate a negative cycle of insomnia and sleep aid use
, , , et al
JCP
Research Participant Feedback on a Suicide Safety Protocol
Original Research

May 15, 2023

In women who triggered a safety protocol as part of a perinatal suicidal ideation study, 50% reported that the protocol increased engagement with treatment, and most reported a “positive...
, , , et al
JCP
Depression Treatment Response Beyond 50% Improvement
Original Research

May 8, 2023

Although most depression treatment research focuses on symptom improvement, patients have additional treatment priorities, including functioning, coping ability, and quality of life.
,
JCP
Low Ghrelin and Anxiety in ARFID
Original Research

May 3, 2023

Low ghrelin levels were associated with greater anxiety in ARFID, indicating a potential target in the treatment of this disorder.
, , , et al
JCP
Endothelial Function in Youth With Bipolar Disorder
Original Research

May 1, 2023

Bipolar disorder (BD) confers risk for accelerated atherosclerosis and early cardiovascular disease. This study found that youth with BD have anomalous reactive hyperemia index (RHI)—a measure of endothelial function—which...
, , , et al
JCP
Abbreviated Suicide Crisis Syndrome Checklist and Decision Making in the ED
Original Research

May 1, 2023

The A-SCS-C had robust clinical utility and reduced clinicians’ reliance on patient-reported suicidal ideation to assess suicide risk in the ED setting.
, , , et al
PCC
Cyberchondria, Quality of Life, and the Moderating Effect of Emotions
Original Research

April 27, 2023

Excessive exposure to copious amount of information, whether of verifiable sources or not, can instigate anxious symptoms in individuals lacking adaptive emotion regulation ability.
, , , et al
PCC
Screening for Bipolar Disorder and Evaluating the RMS
Original Research

April 25, 2023

Health care providers found the Rapid Mood Screener, a new bipolar I disorder screening tool, to be superior to the widely used Mood Disorder Questionnaire in sensitivity/specificity, brevity, practicality,...
, , , et al
JCP
Efficacy of Lumateperone in Bipolar Depression With Mixed Features
Original Research

April 24, 2023

Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with bipolar depression with mixed features.
, , , et al
JCP
Pregnancy-Specific Anxiety Tool: Development and Psychometric Evaluation
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ April 19, 2023

The Pregnancy-Specific Anxiety Tool contributes new dimensions to the measurement of anxiety in pregnancy. Patients scoring higher than 10 on the PSAT require further assessment.
, , , et al
JCP
LAI Implementation After Schizophrenia Diagnosis
Original Research

April 19, 2023

Although long-acting injectable antipsychotic agents (LAIs) are effective in preventing relapse, their use in first-episode schizophrenia was low, and LAIs were rarely the first therapy for early-phase schizophrenia.
, , , et al
PCC
Psychopathology and Remission Pattern of Cannabis-Induced Psychotic Disorder
Original Research

April 18, 2023

The steady improvement noted with complete cessation of cannabis indicates a possible contributory role for cannabis in precipitating psychosis.
, , , et al
JCP
Pandemics and Suicide Rates in Spain: From the Spanish Flu to COVID-19
Original Research

April 17, 2023

Deaths by suicide peaked in Spain during both the Spanish flu and COVID-19 pandemics; however, the stressors that led to these increases differed based on historical context.
, , , et al
JCP
Interpersonal Trauma and Depression Severity in Bipolar Disorder
Original Research

April 10, 2023

In bipolar disorder patients currently receiving treatment, a history of childhood trauma was associated with more severe depression.
, , , et al
JCP
Enhanced Primary Care for People With Serious Mental Illness
Original Research

April 5, 2023

Primary care adapted to the needs of people with SMI improved hemoglobin A1c and systolic blood pressure when compared to usual care.
, , , et al
PCC
Neuropsychiatric Disorders in Patients With HIV-1
Original Research

April 4, 2023

The prevalence and incidence of neuropsychiatric events, as well as health care costs, were similar among people with HIV-1 newly treated with an integrase inhibitor– or protease inhibitor–based regimen.
, , , et al
JCP
Impact of Tardive Dyskinesia on Patient Lives
Original Research

April 3, 2023

This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
, , , et al
PCC
Emotional Intelligence, Personality, and Procrastination in Medical Students
Original Research

March 30, 2023

Higher emotional intelligence was associated with lower procrastination and mediated the relations between neuroticism and openness to experience and procrastination.
, , , et al
JCP
Generalizability of RCTs in First-Episode Schizophrenia
Original Research

March 29, 2023

First-episode schizophrenia patients with suicidal ideation and substance use disorder are often excluded from clinical trials. Omitting them does not affect key outcome measures but excludes many potential subjects.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe